WuXi PharmaTech (WX) Tops Q1 EPS by 1c; Guides Q2 Sales
Tweet Send to a FriendGet Alerts WX Hot Sheet
Trade WX Now!
WuXi PharmaTech (NYSE: WX) reported Q1 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $118 million versus the consensus estimate of $114.19 million.
Sees Q2 2012 revenue of $124-$129 million, versus the consensus of $118.03 million.
For earnings history and earnings-related data on WuXi PharmaTech (WX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees Q2 2012 revenue of $124-$129 million, versus the consensus of $118.03 million.
For earnings history and earnings-related data on WuXi PharmaTech (WX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Donaldson Co., Inc. (DCI) Misses Q3 EPS by 3c; Guides FY13 Below Views
- Orient Paper, Inc. (ONP) Reports Q1 EPS of $0.02; Guides FY13
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
